{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:19:14Z","timestamp":1780391954290,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shenzhen Key Medical Discipline Construction Fund","award":["No.SZXK015"],"award-info":[{"award-number":["No.SZXK015"]}]},{"name":"Guangdong Provincial and National Key Clinical Specialty Construction Project, and National Key Clinical Specialty Construction Project"},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["No.SZSM202411026"],"award-info":[{"award-number":["No.SZSM202411026"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-026-07827-1","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:18:50Z","timestamp":1776698330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparative study of molecular characteristics of pathogenic and uncertain significance variants of BRCA1\/2 in Chinese breast cancer patients"],"prefix":"10.1186","volume":"19","author":[{"given":"Jiayu","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"3","key":"7827_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"7827_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"7827_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103835","volume":"79","author":"M Fu","year":"2025","unstructured":"Fu M, Peng Z, Wu M, Lv D, Li Y, Lyu S. Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050. Breast. 2025;79:103835. https:\/\/doi.org\/10.1016\/j.breast.2024.103835.","journal-title":"Breast"},{"issue":"3","key":"7827_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet. 1998;62(3):676\u201389. https:\/\/doi.org\/10.1086\/301749.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"7827_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s12282-020-01148-2","volume":"28","author":"R Yoshida","year":"2021","unstructured":"Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer. 2021;28(6):1167\u201380. https:\/\/doi.org\/10.1007\/s12282-020-01148-2.","journal-title":"Breast Cancer"},{"issue":"6559","key":"7827_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378(6559):789\u201392. https:\/\/doi.org\/10.1038\/378789a0.","journal-title":"Nature"},{"issue":"5182","key":"7827_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66\u201371. https:\/\/doi.org\/10.1126\/science.7545954.","journal-title":"Science"},{"key":"7827_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.673094","volume":"12","author":"H Abdel-Razeq","year":"2022","unstructured":"Abdel-Razeq H, Tamimi F, Abujamous L, et al. Rates of variants of uncertain significance among patients with breast cancer undergoing genetic testing: regional perspectives. Front Oncol. 2022;12:673094. https:\/\/doi.org\/10.3389\/fonc.2022.673094.","journal-title":"Front Oncol"},{"issue":"8","key":"7827_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/jmedgenet-2019-106368","volume":"57","author":"AN Monteiro","year":"2020","unstructured":"Monteiro AN, Bouwman P, Kousholt AN, et al. Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation. J Med Genet. 2020;57(8):509\u201318. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106368.","journal-title":"J Med Genet"},{"issue":"9","key":"7827_CR10","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1158\/1541-7786.Mcr-19-1108","volume":"18","author":"S Park","year":"2020","unstructured":"Park S, Lee E, Park S, et al. Clinical characteristics and exploratory genomic analyses of germline BRCA1 or BRCA2 mutations in breast cancer. Mol Cancer Res. 2020;18(9):1315\u201325. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-1108.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"7827_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","volume":"19","author":"MB Daly","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, et al. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(1):77\u2013102. https:\/\/doi.org\/10.6004\/jnccn.2021.0001.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"7827_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"7827_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.682445","volume":"11","author":"D Fanale","year":"2021","unstructured":"Fanale D, Fiorino A, Incorvaia L, et al. Prevalence and spectrum of germline BRCA1 and BRCA2 variants of uncertain significance in breast\/ovarian cancer: mysterious signals from the genome. Front Oncol. 2021;11:682445. https:\/\/doi.org\/10.3389\/fonc.2021.682445.","journal-title":"Front Oncol"},{"issue":"9","key":"7827_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s10038-024-01263-4","volume":"69","author":"L Zhang","year":"2024","unstructured":"Zhang L, Shen M, Shu X, et al. The recommendation of re-classification of variants of uncertain significance (VUS) in adult genetic disorders patients. J Hum Genet. 2024;69(9):425\u201331. https:\/\/doi.org\/10.1038\/s10038-024-01263-4.","journal-title":"J Hum Genet"},{"issue":"4","key":"7827_CR15","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4143\/crt.2021.978","volume":"54","author":"JS Park","year":"2022","unstructured":"Park JS, Shin S, Lee YJ, et al. Implication and influence of multigene panel testing with genetic counseling in Korean patients with BRCA1\/2 mutation-negative breast cancer. Cancer Res Treat. 2022;54(4):1099\u2013110. https:\/\/doi.org\/10.4143\/crt.2021.978.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"7827_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/pjp.2024.135703","volume":"75","author":"N Eras","year":"2024","unstructured":"Eras N, Tuncel F, Alt\u0131ntas Z, Erden S. Clinicopathological characteristics and BRCA1\/BRCA2 pathogenic variants of patients with breast cancer. Pol J Pathol. 2024;75(1):1\u20137. https:\/\/doi.org\/10.5114\/pjp.2024.135703.","journal-title":"Pol J Pathol"},{"key":"7827_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2107-6","volume":"16","author":"WM Cao","year":"2016","unstructured":"Cao WM, Gao Y, Yang HJ, et al. Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast\/ovarian cancer. BMC Cancer. 2016;16:64. https:\/\/doi.org\/10.1186\/s12885-016-2107-6.","journal-title":"BMC Cancer"},{"issue":"1","key":"7827_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211070757","volume":"50","author":"S Kharel","year":"2022","unstructured":"Kharel S, Shrestha S, Yadav S, Shakya P, Baidya S, Hirachan S. BRCA1\/BRCA2 mutation spectrum analysis in South Asia: a systematic review. J Int Med Res. 2022;50(1):3000605211070757. https:\/\/doi.org\/10.1177\/03000605211070757.","journal-title":"J Int Med Res"},{"key":"7827_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/632870","volume":"2011","author":"A Farooq","year":"2011","unstructured":"Farooq A, Naveed AK, Azeem Z, Ahmad T. Breast and ovarian cancer risk due to prevalence of BRCA1 and BRCA2 variants in Pakistani population: a Pakistani database report. J Oncol. 2011;2011:632870. https:\/\/doi.org\/10.1155\/2011\/632870.","journal-title":"J Oncol"},{"issue":"5","key":"7827_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.clbc.2018.02.007","volume":"18","author":"JS Park","year":"2018","unstructured":"Park JS, Lee ST, Han JW, Kim TI, Nam EJ, Park HS. Difference in risk of breast and ovarian cancer according to putative functional domain regions in Korean BRCA1\/2 mutation carriers. Clin Breast Cancer. 2018;18(5):362-373.e1. https:\/\/doi.org\/10.1016\/j.clbc.2018.02.007.","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"7827_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mgg3.120","volume":"3","author":"Y Hirotsu","year":"2015","unstructured":"Hirotsu Y, Nakagomi H, Sakamoto I, Amemiya K, Mochizuki H, Omata M. Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing. Mol Genet Genomic Med. 2015;3(2):121\u20139. https:\/\/doi.org\/10.1002\/mgg3.120.","journal-title":"Mol Genet Genomic Med"},{"issue":"3","key":"7827_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/humu.23965","volume":"41","author":"X Gao","year":"2020","unstructured":"Gao X, Nan X, Liu Y, et al. Comprehensive profiling of BRCA1 and BRCA2 variants in breast and ovarian cancer in Chinese patients. Hum Mutat. 2020;41(3):696\u2013708. https:\/\/doi.org\/10.1002\/humu.23965.","journal-title":"Hum Mutat"},{"issue":"1","key":"7827_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijc.30692","volume":"141","author":"GT Lang","year":"2017","unstructured":"Lang GT, Shi JX, Hu X, et al. The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: screening of 2,991 patients and 1,043 controls by next-generation sequencing. Int J Cancer. 2017;141(1):129\u201342. https:\/\/doi.org\/10.1002\/ijc.30692.","journal-title":"Int J Cancer"},{"issue":"3","key":"7827_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10549-009-0385-2","volume":"117","author":"A Kwong","year":"2009","unstructured":"Kwong A, Wong LP, Wong HN, et al. A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat. 2009;117(3):683\u20136. https:\/\/doi.org\/10.1007\/s10549-009-0385-2.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"7827_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043994","volume":"7","author":"A Kwong","year":"2012","unstructured":"Kwong A, Ng EK, Wong CL, et al. Identification of BRCA1\/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. PLoS One. 2012;7(9):e43994. https:\/\/doi.org\/10.1371\/journal.pone.0043994.","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"7827_CR26","first-page":"4","volume":"24","author":"A Kwong","year":"2018","unstructured":"Kwong A, Shin VY, Ma ES, et al. Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations. Hong Kong Med J Jun. 2018;24(Suppl 3):4\u20136.","journal-title":"Hong Kong Med J Jun"},{"issue":"4","key":"7827_CR27","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e60","volume":"30","author":"JY Chern","year":"2019","unstructured":"Chern JY, Lee SS, Frey MK, Lee J, Blank SV. The influence of BRCA variants of unknown significance on cancer risk management decision-making. J Gynecol Oncol. 2019;30(4):e60. https:\/\/doi.org\/10.3802\/jgo.2019.30.e60.","journal-title":"J Gynecol Oncol"},{"key":"7827_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00301","volume":"10","author":"S Wu","year":"2020","unstructured":"Wu S, Zhou J, Zhang K, et al. Molecular mechanisms of PALB2 function and its role in breast cancer management. Front Oncol. 2020;10:301. https:\/\/doi.org\/10.3389\/fonc.2020.00301.","journal-title":"Front Oncol"},{"issue":"2","key":"7827_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkz028","volume":"3","author":"S Yost","year":"2019","unstructured":"Yost S, Ruark E, Alexandrov LB, Rahman N. Insights into BRCA cancer predisposition from integrated germline and somatic analyses in 7632 cancers. JNCI Cancer Spectr. 2019;3(2):pkz028. https:\/\/doi.org\/10.1093\/jncics\/pkz028.","journal-title":"JNCI Cancer Spectr"},{"key":"7827_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104109","volume":"190","author":"E Zattarin","year":"2023","unstructured":"Zattarin E, Taglialatela I, Lobefaro R, et al. Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: different biological and clinical entities with potentially diverse therapeutic opportunities. Crit Rev Oncol Hematol. 2023;190:104109. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104109.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"14","key":"7827_CR31","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1200\/jco-24-01334","volume":"43","author":"M Lambertini","year":"2025","unstructured":"Lambertini M, Blondeaux E, Tomasello LM, et al. Clinical behavior of breast cancer in young BRCA carriers and prediagnostic awareness of germline BRCA status. J Clin Oncol. 2025;43(14):1706\u201319. https:\/\/doi.org\/10.1200\/jco-24-01334.","journal-title":"J Clin Oncol"},{"issue":"12","key":"7827_CR32","doi-asserted-by":"publisher","first-page":"13019","DOI":"10.1002\/cam4.5976","volume":"12","author":"M Ni","year":"2023","unstructured":"Ni M, Wang F, Yang A, et al. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. Cancer Med. 2023;12(12):13019\u201330. https:\/\/doi.org\/10.1002\/cam4.5976.","journal-title":"Cancer Med"},{"issue":"2","key":"7827_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10549-020-05643-0","volume":"181","author":"C Zeng","year":"2020","unstructured":"Zeng C, Guo X, Wen W, et al. Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women. Breast Cancer Res Treat. 2020;181(2):465\u201373. https:\/\/doi.org\/10.1007\/s10549-020-05643-0.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7827_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01554-6","volume":"39","author":"G Federici","year":"2020","unstructured":"Federici G, Soddu S. Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers. J Exp Clin Cancer Res. 2020;39(1):46. https:\/\/doi.org\/10.1186\/s13046-020-01554-6.","journal-title":"J Exp Clin Cancer Res"},{"key":"7827_CR35","doi-asserted-by":"publisher","unstructured":"Zanti M, O\u2019Mahony DG, Parsons MT, et al. Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification. medRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.09.04.24313051.","DOI":"10.1101\/2024.09.04.24313051"},{"issue":"1","key":"7827_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08863-9","volume":"21","author":"JF Creeden","year":"2021","unstructured":"Creeden JF, Nanavaty NS, Einloth KR, et al. Homologous recombination proficiency in ovarian and breast cancer patients. BMC Cancer. 2021;21(1):1154. https:\/\/doi.org\/10.1186\/s12885-021-08863-9.","journal-title":"BMC Cancer"},{"issue":"5","key":"7827_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41436-019-0740-6","volume":"22","author":"JN Dines","year":"2020","unstructured":"Dines JN, Shirts BH, Slavin TP, et al. Systematic misclassification of missense variants in BRCA1 and BRCA2 \u201ccoldspots.\u201d Genet Med. 2020;22(5):825\u201330. https:\/\/doi.org\/10.1038\/s41436-019-0740-6.","journal-title":"Genet Med"},{"key":"7827_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/gpbjnl\/qzaf072","author":"S Zhang","year":"2025","unstructured":"Zhang S, Chen X, Jin E, et al. The GSA family in 2025: a broadened sharing platform for multi-omics and multimodal data. Genomics Proteomics Bioinformatics. 2025. https:\/\/doi.org\/10.1093\/gpbjnl\/qzaf072.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"D1","key":"7827_CR39","doi-asserted-by":"publisher","first-page":"D30","DOI":"10.1093\/nar\/gkae978","volume":"6","author":"Database Resources of the National Genomics Data Center","year":"2025","unstructured":"Database Resources of the National Genomics Data Center. China National Center for Bioinformation in 2025. Nucleic Acids Res Jan. 2025;6(D1):D30\u201344. https:\/\/doi.org\/10.1093\/nar\/gkae978.","journal-title":"Nucleic Acids Res Jan"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-026-07827-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07827-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07827-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:45:07Z","timestamp":1780389907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13104-026-07827-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7827"],"URL":"https:\/\/doi.org\/10.1186\/s13104-026-07827-1","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study were approved by the ethics committee of the Shenzhen People\u2019s Hospital of Guangdong Province (No. LL-KY-2025124-02) and conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from the participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}